RESUMEN
BACKGROUND: Cognitive impairment has emerged as an important concern in clinical practice in aging population. Several comorbid factors contribute to etiopathogenesis; one disease of interest is chronic respiratory disease. AIM: The aim of this study is to investigate the association of chronic respiratory disease with risk of cognitive impairment in older Mexicans. MATERIALS AND METHODS: Data were obtained from 2782 Mexicans, aged ≥60 years, enrolled in waves I (2001) and III (2012) of the Mexican Health and Aging Study, a prospective cohort of nationally representative sample of older Mexicans. Participants' self-reported responses were used to categorize them into having respiratory disease or not. Study outcome included participants categorized into "cognitively impaired" or "cognitively normal" groups. Multivariable logistic regression models were used to investigate the relationship. RESULTS: Overall, 16% of cohort participants reported cognitively impaired at Wave III. Compared with older Mexicans without chronic respiratory disease diagnosis, those diagnosed were not significantly associated with risk of cognitive impairment [adjusted odds ratio (OR): 0.94, 95% confidence interval (CI): 0.58-1.58]. CONCLUSION: Chronic respiratory disease is not significantly associated with risk of cognitive impairment in older Mexican adults.
Asunto(s)
Disfunción Cognitiva/etiología , Trastornos Respiratorios/complicaciones , Anciano , Femenino , Estudios de Seguimiento , Humanos , Masculino , México , Persona de Mediana Edad , Estudios ProspectivosRESUMEN
BACKGROUND: Vitamin D is essential for maintaining bone mineralization and calcium homeostasis, and prevents falls and fractures in older adults. Mexico is undergoing an epidemiologic and demographic transition with increasing obesity rates. The study's aim was to determine the association of obesity with serum 25-hydroxyvitamin D [25(OH)D] concentrations in older Mexican adults. METHODS: Data from 1772 Mexicans, aged ≥50 years, enrolled in a sub-sample of the 3rd wave of the Mexican Health and Aging Study, were included. Serum 25(OH)D concentrations were used to define vitamin D status, and were categorized into tertiles. Body mass index measures were used to categorize older adults into under/normal weight, overweight, and obese groups. Multinomial logistic regression models were used to assess the relationship, adjusting for potential confounders. RESULTS: Approximately 40% and 37% of older Mexican adults were either overweight or obese, respectively. Compared to under/normal weight older Mexicans, obese adults were 1.78 times (95% Confidence Interval (CI) 1.27-2.48) and 1.94 times (95% CI 1.40-2.68) more associated with the first and second tertile concentrations of serum 25(OH)D, respectively. Overweight adults were 1.52 times (95% CI 1.12-2.06) more associated with the second tertile of serum 25(OH)D concentration than under/normal weight adults. CONCLUSION: Overweight/Obesity was found to be significantly associated with low concentrations of serum 25(OH) in older Mexican adults.
Asunto(s)
Obesidad/sangre , Deficiencia de Vitamina D/sangre , Vitamina D/análogos & derivados , Anciano , Envejecimiento , Índice de Masa Corporal , Femenino , Estado de Salud , Humanos , Masculino , México , Persona de Mediana Edad , Sobrepeso/sangre , Vitamina D/sangre , Circunferencia de la CinturaRESUMEN
OBJECTIVE: This study investigated the risk of cognitive and functional impairment in older Mexicans diagnosed with arthritis. Participants included 2,681 Mexicans, aged ≥60 years, enrolled in the Mexican Health and Aging Study cohort. METHOD: Participants were categorized into arthritis and no arthritis exposure groups. Primary outcome included participants categorized into "cognitively impaired" or "cognitively normal" groups. Secondary outcomes included participants categorized into Normal, Functionally Impaired only, Cognitively Impaired only, or Dementia (both cognitively and functionally impaired) groups. Multivariable logistic and multinomial regression models were used to assess the relationships. RESULTS: Overall, 16% or 7% were diagnosed with cognitive impairment or dementia. Compared with older Mexicans without arthritis, those who were diagnosed with arthritis had significantly increased risk of functional impairment (adjusted odds ratio [OR] 1.82, 95% confidence interval [CI] = [1.45, 2.29]), but not of dementia. CONCLUSION: Arthritis is associated with increased risk of functional impairment, but not with dementia after 11 years in older Mexicans.
Asunto(s)
Artritis , Disfunción Cognitiva/epidemiología , Disfunción Cognitiva/etiología , Personas con Discapacidad , Anciano , Femenino , Humanos , Modelos Logísticos , Masculino , México/epidemiología , Persona de Mediana Edad , Medición de RiesgoRESUMEN
OBJECTIVES: To create a risk index (Mexican American Dementia Nomogram (MADeN)) that predicts dementia over a 10-year period for Mexican Americans aged 65 and older. DESIGN: Retrospective cohort study with longitudinal analysis. SETTING: Texas, New Mexico, Colorado, Arizona, and California. PARTICIPANTS: Hispanic Established Populations for the Epidemiologic Study of the Elderly (H-EPESE) participants (n = 1,739). MEASUREMENTS: Dementia was defined as a decline of three or more points per year on the Mini-Mental State Examination and inability to perform one or more daily activities. Candidate risk factors included demographic characteristics, measures of social engagement, self-reported health conditions, ability to perform daily activities, and physical activity. RESULTS: The MADeN comprised the following risk factors: age, sex, education, not having friends to count on, not attending community events, diabetes mellitus, feeling the blues, pain, impairment in instrumental activities of daily living, and unable to walk a half-mile. The area under the receiver operating characteristic curve was 0.74 (95% confidence interval (CI) = 0.70-0.78) and a score of 16 points or higher had a sensitivity of 0.65 (95% CI = 0.59-0.72) and specificity of 0.70 (95% CI = 0.67-0.73) in predicting dementia. CONCLUSION: The MADeN was able to predict dementia in a population of older Mexican-American adults with moderate accuracy. It has the potential to identify older Mexican-American adults who may benefit from interventions to reduce dementia risk and to educate this population about risk factors for dementia.
Asunto(s)
Demencia/diagnóstico , Evaluación Geriátrica/métodos , Americanos Mexicanos , Anciano , Anciano de 80 o más Años , Demencia/clasificación , Demencia/epidemiología , Femenino , Humanos , Estudios Longitudinales , Masculino , Nomogramas , Valor Predictivo de las Pruebas , Estudios Retrospectivos , Factores de Riesgo , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: Several dementia risk indices have been developed for older adults in high-income countries. However, no index has been developed for populations in low- or middle-income countries. OBJECTIVE: To create a risk index for predicting severe cognitive impairment among adults aged ≥60 in Mexico and to compare the accuracy of this index to the Dementia Screening Indicator (DSI). METHODS: This study included 3,002 participants from the Mexican Health and Aging Study (MHAS) interviewed in 2001 and 2012. The MHAS risk index included sociodemographic, health, and functional characteristics collected in 2001. A point value based on the beta coefficients from a multivariable logistic regression model was assigned to each risk factor and the total score was calculated. RESULTS: The MHAS risk index (AUCâ=â0.74 95% CIâ=â0.70-0.77) and DSI (AUCâ=â0.72 95% CIâ=â0.69-0.77) had similar accuracy for discriminating between participants who developed severe cognitive impairment from those who did not. A score of ≥16 on the MHAS risk index had a sensitivity of 0.69 (95% CIâ=â0.64-0.70) and specificity of 0.67 (95% CIâ=â0.66-0.69). A score of ≥23 on the DSI had a sensitivity of 0.56 (95% CIâ=â0.50-0.63) and specificity of 0.78 (95% CIâ=â0.76-0.79). DISCUSSION: The MHAS risk index and DSI have moderate accuracy for predicting severe cognitive impairment among older adults in Mexico. This provides evidence that existing dementia risk indices may be applicable in low- and middle-income countries such as Mexico. Future research should seek to identify additional risk factors that can improve the accuracy of the MHAS risk index.